COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
Provided By PR Newswire
Last update: May 28, 2025
- In Q1 following a development achievement, CollPlant received a $2 million payment from AbbVie –
- Advancement of regenerative breast implant program continues; encouraging findings continue to be observed -
Read more at prnewswire.comNASDAQ:CLGN (11/4/2025, 2:17:45 PM)
2.23
-0.05 (-2.19%)
Find more stocks in the Stock Screener
